Interestingly, ERK inhibitor treatment rescues the molecular, anatomical and behavioral deficits of 16p11.2 (one of the most common gene copy number variations linked to autism) deletion in mice [192], and newly developed ERK pathway inhibitor peptides ameliorate defective synaptogenesis in the Kras12V mouse model [120]. The gene discussed is MAPK1; the disease is autism.